Dermis disorder
MONDO:0021154A disease that involves the dermis.
Also known as: dermis disease, dermis disease or disorder, disease of dermis, disease or disorder of dermis, disorder of dermis, other dermis disorder
103 clinical trials for this condition and its sub-types, 0 tagged with Dermis disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Dermis disorder
-
Dermis tumor 0 trials · 90 incl. sub-types
8 sub-types
- Malignant dermis tumor 0 trials · 87 incl. sub-types Sub-types →
- Leiomyoma cutis 2 trials Sub-types →
- Cutaneous fibrous histiocytoma 1 trial
- Cutaneous granular cell tumor 0 trials · 1 incl. sub-types Sub-types →
- Cutaneous mastocytosis 1 trial Sub-types →
- Skin glomus tumor 1 trial Sub-types →
- Angioma serpiginosum 0 trials Sub-types →
- Juvenile hyaline fibromatosis 0 trials
-
Primary cutaneous amyloidosis 4 trials · 5 incl. sub-types
5 sub-types
- Lichen amyloidosis 2 trials
- Familial primary localized cutaneous amyloidosis 1 trial Sub-types →
- Macular amyloidosis 1 trial
- Amyloidosis cutis dyschromia 0 trials
- Nodular cutaneous amyloidosis 0 trials
-
Primary anetoderma 4 trials
-
Mixed dermis disorder 0 trials · 3 incl. sub-types
6 sub-types
- Aplasia cutis congenita 3 trials Sub-types →
- Aplasia cutis congenita-intestinal lymphangiectasia syndrome 0 trials
- Linear skin defects with multiple congenital anomalies 0 trials Sub-types →
- Recessive aplasia cutis congenita of limbs 0 trials
- Scalp defects-postaxial polydactyly syndrome 0 trials
- Scalp-ear-nipple syndrome 0 trials
-
Elastoma 1 trial
-
Annular erythema of infancy 0 trials
-
Antecubital pterygium syndrome 0 trials
-
Atrophoderma of Pierini and Pasini 0 trials
-
Confetti-like macular atrophy 0 trials
-
Dermochondrocorneal dystrophy 0 trials
-
Elastoderma 0 trials
-
Elastosis perforans serpiginosa 0 trials
-
Familial anetoderma 0 trials
-
Familial cutaneous collagenoma 0 trials
-
Late-onset focal dermal elastosis 0 trials
-
Lichen myxedematosus 0 trials
3 sub-types
- Atypical lichen myxedematosus 0 trials Sub-types →
- Localized lichen myxedematosus 0 trials Sub-types →
- Scleromyxedema 0 trials
-
Linear atrophoderma of Moulin 0 trials
-
Linear focal dermal elastosis 0 trials
-
Lipoid proteinosis 0 trials
-
Mid-dermal elastolysis 0 trials
-
Necrobiosis lipoidica 0 trials
-
Papular elastorrhexis 0 trials
-
Primary cutis verticis gyrata 0 trials
3 sub-types
-
Progressive osseous heteroplasia 0 trials
-
White fibrous papulosis of the neck 0 trials
Most studied deeper sub-types
-
Can a new antibody help the immune system fight Hard-to-Treat tumors?
Disease control CompletedThis trial tests an experimental drug called SNS-101, which targets a protein called VISTA that may help tumors evade the immune system. Researchers give SNS-101 alone or with another immunotherapy, cemiplimab, to adults with advanced solid tumors that have not responded to stand…
Phase 1/2 • Sponsor: Sensei Biotherapeutics, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Immunotherapy plus precision radiation shows promise for rare skin cancer
Disease control CompletedThis phase II trial tested whether adding stereotactic body radiation therapy (SBRT) to the immunotherapy drug pembrolizumab (Keytruda) works better than pembrolizumab alone for advanced Merkel cell carcinoma, a rare and aggressive skin cancer. Nine patients with metastatic disea…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New combo therapy shows promise for rare sarcomas
Disease control CompletedThis study looked at adding the drug pazopanib to standard radiation or chemoradiation before surgery for patients with certain soft tissue sarcomas. The goal was to see if the combination is safe and helps shrink tumors more effectively. About 140 adults and children with newly …
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug BDB001 tested in patients whose tumors resisted standard immunotherapy
Disease control CompletedThis study tested an experimental drug called BDB001 in people with advanced solid tumors (like skin, lung, or kidney cancer) that had stopped responding to standard immunotherapy. The goal was to see if BDB001 could shrink tumors or slow their growth. Only one person took part, …
Phase 2 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Laser zaps skin amyloid deposits in rare itching disorder
Symptom relief CompletedResearchers at Tanta University are testing whether fractional CO2 laser can reduce skin amyloid deposits and itching in people with primary cutaneous amyloidosis. The trial enrolls 22 adults with confirmed disease who have not used other treatments for at least six months. Parti…
Sponsor: Tanta University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Blue dye and red light: a new hope for itchy skin?
Symptom relief CompletedThis pilot study tested whether applying methylene blue (a dye) to skin lesions and then shining red light on them could improve skin roughness in people with lichen amyloidosis, a condition causing itchy, bumpy patches. Fifteen Asian adults with the condition received the treatm…
Sponsor: Chulalongkorn University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could a UV laser smooth out this rare skin condition?
Symptom relief CompletedThis pilot study tested a 308-nm excimer laser on 15 Asian adults with lichen amyloidosis, a condition that causes itchy, rough patches on the skin. The goal was to see if the laser could improve skin roughness. The study is small and early, so results are not conclusive.
Sponsor: Chulalongkorn University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Scientists track severe allergies to uncover hidden patterns
Knowledge-focused CompletedThis completed study followed 945 people, mostly children and young adults with severe eczema or related allergic conditions, along with their relatives. Researchers observed how these diseases progress over up to a year, using tests like allergy skin pricks, blood draws, and lun…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
A new tool aims to demystify immunotherapy for advanced cancer patients
Knowledge-focused CompletedThis trial tests whether a 15-minute educational video and a list of suggested questions can improve understanding of immunotherapy among patients with advanced cancer and their caregivers. Participants are randomly assigned to receive the educational materials or usual care, and…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Cancer patients may not need lifelong immunotherapy, study suggests
Knowledge-focused CompletedThis study looked at people with advanced solid tumors (like lung, bladder, or melanoma) who had been on immunotherapy for one year and whose disease was stable. Half stopped treatment and half continued. The goal was to see if stopping early affected how long until the cancer pr…
Phase 3 • Sponsor: Dan Zandberg • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Dental study tests which elastic works best for tooth movement
Knowledge-focused CompletedThis study compared two methods—elastic chains and elastics—for moving canine teeth backward after premolar extraction. Thirty-three orthodontic patients participated, and researchers measured how fast and how straight the teeth moved. The goal was to find a more effective way to…
Sponsor: Sana'a University • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:43 UTC